As the market access landscape evolves, the bar for evidence is shifting.
Payers aren’t looking for more data. They’re looking for the right data. They want real-world relevance, economic clarity, and justification that feels grounded in practice. Too often, HEOR strategies are built in a vacuum. Teams make assumptions about what matters to payers, then realize too late they missed the mark.
That’s why the smartest access teams are validating early. Before finalizing evidence packages, they’re pressure-testing with current decision-makers:
1. Are our assumptions aligned with payer expectations?
2. Are we over- or under-weighting certain endpoints?
3. Will this data resonate or raise red flags?
It’s not about chasing approval. It’s about designing evidence that stands up to scrutiny.
This kind of pre-submission input can’t wait for a formal advisory board. It needs to happen at the speed of launch planning. That’s where real-time engagement platforms can quietly play a critical role, offering a checkpoint between internal alignment and external execution.
If you want to explore how to build this kind of early validation into your evidence strategy, connect with us today.